Norethindrone
- CAS No.
- 68-22-4
- Chemical Name:
- Norethindrone
- Synonyms
- Elk;ENT;NET;Cek6;Elkh;Hek6;EPB1;EPHB1;EPHT2;EPTH2
- CBNumber:
- CB0455127
- Molecular Formula:
- C20H26O2
- Molecular Weight:
- 298.43
- MOL File:
- 68-22-4.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/6/13 17:03:25
| Melting point | 205-206 °C (lit.) |
|---|---|
| alpha | D20 -31.7° (chloroform); D20 -25° (chloroform) |
| Boiling point | 379.83°C (rough estimate) |
| Density | 1.0766 (rough estimate) |
| refractive index | 1.4800 (estimate) |
| storage temp. | 2-8°C |
| solubility | chloroform: ≥50 mg/mL, clear, colorless |
| pka | 13.09±0.40(Predicted) |
| form | powder |
| color | white to off-white |
| Water Solubility | 7.043mg/L(25 ºC) |
| Merck | 6697 |
| BRN | 1915671 |
| BCS Class | 1 |
| InChIKey | VIKNJXKGJWUCNN-XGXHKTLJSA-N |
| CAS DataBase Reference | 68-22-4(CAS DataBase Reference) |
| NIST Chemistry Reference | Norethindrone(68-22-4) |
| EPA Substance Registry System | Norethisterone (68-22-4) |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS08,GHS09 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H351-H360FD-H362-H410 | |||||||||
| Precautionary statements | P202-P260-P263-P264-P273-P308+P313 | |||||||||
| Hazard Codes | Xn | |||||||||
| Risk Statements | 40-36/37/38-20/21/22 | |||||||||
| Safety Statements | 22-36/37/39-45-37/39-26 | |||||||||
| RIDADR | UN 3077 9 / PGIII | |||||||||
| WGK Germany | 3 | |||||||||
| RTECS | RC8975000 | |||||||||
| HS Code | 29144000 | |||||||||
| Toxicity | LD50 oral in mouse: 6gm/kg | |||||||||
| NFPA 704 |
|
Norethindrone price More Price(8)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich(India) | N4128 | 19-Norethindrone ≥98%, powder | 68-22-4 | 50MG | ₹3788.75 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | N4128 | 19-Norethindrone ≥98%, powder | 68-22-4 | 250MG | ₹10023.95 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | SAB4500732 | Anti-EPHB1 antibody produced in rabbit affinity isolated antibody | 68-22-4 | 100μG | ₹50560.5 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | N4128 | 19-Norethindrone ≥98%, powder | 68-22-4 | 1G | ₹17742.18 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | PHR1714 | Norethindrone (Norethisterone) Pharmaceutical Secondary Standard; Certified Reference Material | 68-22-4 | 1G | ₹23923.25 | 2022-06-14 | Buy |
Norethindrone Chemical Properties,Uses,Production
Description
Norethindrone is a progestin (a synthetic substance with properties similar to progesterone) that is best known as the first female oral contraceptive, or the “pill.”Norethindrone’s global impact on society and culture has made it one of the most important inventions in history.
Chemical Properties
Off-White to Pale Yellow Solid
History
The development of norethindrone as a female oral contraceptive took place indirectly over 30 years as a result of steroid research.This research accelerated in the 1930s when structures and medical applications of steroidal compounds were determined.Steroids are lipids, which include cholesterol, bile salts,and sex hormones,that are characterized by a structure of three fused six-carbon rings and a five-carbon ring.
In 1957, both norethindrone and norethynodrel were approved by the Food and Drug Administration (FDA) for treating menstrual problems and infertility. In 1960, the FDA approved Searle's norethynodrel under the trade name Enovid. Norethindrone was approved as an oral contraceptive in 1962 under the trade name Ortho-Novum.
Uses
Progesteron. Norethindrone and acetate in combination with estrogen as contraceptive (oral). It is reasonably anticipated to be a human carcinogen
Definition
ChEBI: A 17beta-hydroxy steroid that is testosterone in which the hydrogen at position 17 is replaced by an ethynyl group and in which the methyl group attached to position 10 is replaced by hydrogen.
Side effects
Some of the more common side effects of Norethindrone include breast tenderness, hair growth, especially on the face; pimples, weight gain, frequent and irregular bleeding; and menstrual changes. Possible side effects may include: blindness, blue-yellow colour blindness, breast pain, tightness in the chest, chills, clay-coloured stools, cough, dark-coloured urine, diarrhoea, difficulty swallowing, headache and dizziness, eye pain, fast heartbeat, feeling sad or empty, fever, general tiredness and weakness, heavy non-menstrual vaginal bleeding, hives, itching or rash, loss of appetite, puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue Swelling; Stomach ache, etc.
Safety Profile
Confirmed carcinogen with experimental carcinogenic, tumorigenic, and teratogenic data. Mddly toxic by ingestion. Human systemic effects by ingestion: dermatitis and androgenic effects. Human teratogenic effects: developmental abnormalities of the musculoskeletal system and urogenital system; and behavioral effects in the newborn. Human reproductive effects: spermatogenesis; testes, epididymis, sperm duct changes; impotence; male breast development; other male effects; ovaries, fallopian tube changes; menstrual cycle effects; postpartum effects; changes in female fertility. Experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits acrid smoke and irritating fumes.
Carcinogenicity
Norethisterone is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity from studies in experimental animals.
Norethindrone Preparation Products And Raw materials
Raw materials
1of4
chevron_rightPreparation Products
| Supplier | Tel | Country | ProdList | Advantage | Inquiry |
|---|---|---|---|---|---|
| SynThink RESEARCH CHEMICALS | +91-8177860948 +91-8177860948 | Mumbai, India | 494 | 58 | Inquiry |
| Coral Drugs Pvt Ltd | +91-1244518100 +91-8199986118 | New Delhi, India | 24 | 58 | Inquiry |
| Medi Pharma Drug House | +919930911911 | Mumbai, India | 143 | 58 | Inquiry |
| Asg Biochem Pvt. Ltd | +91-9650436669 +91-9650436669 | New Delhi, India | 25 | 58 | Inquiry |
| La Chandra Pharmalab Pvt. Ltd. | +91-9099028738 +91-9099028738 | Gujarat, India | 8 | 58 | Inquiry |
| Shakti Life Science | +91-9930420063 +91-9930420063 | Maharashtra, India | 28 | 58 | Inquiry |
| Ralington Pharma | +91-7948911722 +91-9687771722 | Gujarat, India | 1350 | 58 | Inquiry |
| Prachem Laboratories | +91-7948993109 +91-7383072020 | Gujarat, India | 44 | 58 | Inquiry |
| Brichem Life Sciences Pvt Ltd | +91-9879109660 +91-9427536568 | Gujarat, India | 11 | 58 | Inquiry |
| Symbiotec Pharma Lab Pvt Ltd | +91-7316676406 +91-7316676405 | Madhya Pradesh, India | 71 | 58 | Inquiry |
| Supplier | Advantage |
|---|---|
| SynThink RESEARCH CHEMICALS | 58 |
| Coral Drugs Pvt Ltd | 58 |
| Medi Pharma Drug House | 58 |
| Asg Biochem Pvt. Ltd | 58 |
| La Chandra Pharmalab Pvt. Ltd. | 58 |
| Shakti Life Science | 58 |
| Ralington Pharma | 58 |
| Prachem Laboratories | 58 |
| Brichem Life Sciences Pvt Ltd | 58 |
| Symbiotec Pharma Lab Pvt Ltd | 58 |
68-22-4(Norethindrone)Related Search:
1of4
chevron_right